Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02973711
Title A Phase I/II Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

chronic myeloid leukemia

Therapies

Nilotinib + Ruxolitinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field